within Pharmacolibrary.Drugs.ATC.S;

model S01BA07
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 3.3333333333333335e-07,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 2e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01BA07</td></tr><td>route:</td><td>ophthalmic</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Fluorometholone is a synthetic corticosteroid primarily used in ophthalmology to treat inflammatory conditions of the eye, such as allergic conjunctivitis, iritis, and post-operative ocular inflammation. It is typically administered as eye drops and is approved for topical ocular use.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for topical ophthalmic administration in adults. No direct published pharmacokinetic parameters in humans; values are based on approximation from corticosteroid ocular disposition and limited animal or in vitro data.</p><h4>References</h4><ol><li><p>Baba, K, et al., &amp; Nishida, K (2021). The generation of fluorometholone nanocrystal eye drops, their metabolization to dihydrofluorometholone and penetration into rabbit eyes. <i>International journal of pharmaceutics</i> 592 120067–None. DOI:<a href=\"https://doi.org/10.1016/j.ijpharm.2020.120067\">10.1016/j.ijpharm.2020.120067</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33189813/\">https://pubmed.ncbi.nlm.nih.gov/33189813</a></p></li><li><p>Lee, H, et al., &amp; Kim, SW (2023). Corticosteroid-Antibiotic Interactions in Bacteria that Cause Corneal Infection. <i>Translational vision science &amp; technology</i> 12(5) 16–None. DOI:<a href=\"https://doi.org/10.1167/tvst.12.5.16\">10.1167/tvst.12.5.16</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37184498/\">https://pubmed.ncbi.nlm.nih.gov/37184498</a></p></li><li><p>Schoenwald, RD, et al., &amp; Chien, DS (1987). Ophthalmic bioequivalence of steroid/antibiotic combination formulations. <i>Biopharmaceutics &amp; drug disposition</i> 8(6) 527–548. DOI:<a href=\"https://doi.org/10.1002/bdd.2510080605\">10.1002/bdd.2510080605</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3427210/\">https://pubmed.ncbi.nlm.nih.gov/3427210</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01BA07;
